Pregnancy Complications
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
DexcomCA - San Diego
2 programsContinuous glucose monitoring deviceN/A1 trial
continuous blood glucose monitoring in a subset of womenN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
Human BioSciencesStep count goal
Dexcomcontinuous blood glucose monitoring in a subset of women
DexcomContinuous glucose monitoring device
Clinical Trials (3)
Total enrollment: 568 patients across 3 trials
Psychobiological Interventions in Pregnancy
Start: Jan 2025Est. completion: Jun 202788 patients
N/AEnrolling By Invitation
Early Versus Late Monitoring Among Pregnant Women With a History of Gestational Diabetes
Start: Nov 2023Est. completion: Dec 2026200 patients
N/ARecruiting
Correlation of CGM Metrics With OGTT and Pregnancy Outcomes in Pregnant Women With or Without a High Risk for GDM
Start: Jan 2022Est. completion: Nov 2024280 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 568 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.